Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 8/20 | 0.52 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.49 |
| ▸ | BACE1 | P56817 | 5/20 | 0.48 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CCNC | P24863 | 1/20 | 0.43 |
| ▸ | CDK8 | P49336 | 1/20 | 0.43 |
| ▸ | CSF1R | P07333 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL709010 | 0.84 | GPR119 (0.55) | GPR119EGLN2BACE1IRAK4LMNA | |
| SCHEMBL532948 | 0.84 | GPR119 (0.55) | GPR119EGLN2IRAK4LMNAALDH1A1 | |
| SCHEMBL30062832 | 0.84 | GPR119 (0.51) | GPR119EGLN2BACE1IRAK4CCNC | |
| SCHEMBL631353 | 0.83 | GPR119 (0.54) | GPR119EGLN2IRAK4LMNAALDH1A1 | |
| SCHEMBL356713 | 0.83 | GPR119 (0.54) | GPR119EGLN2BACE1IRAK4LMNA | |
| SCHEMBL30062534 | 0.83 | GPR119 (0.54) | GPR119EGLN2IRAK4LMNAALDH1A1 | |
| SCHEMBL355131 | 0.83 | GPR119 (0.68) | GPR119EGLN2 | |
| SCHEMBL13156287 | 0.83 | GPR119 (0.54) | GPR119EGLN2IRAK4LMNAALDH1A1 | |
| SCHEMBL29378266 | 0.83 | GPR119 (0.68) | GPR119EGLN2 | |
| SCHEMBL30061047 | 0.83 | GPR119 (0.49) | GPR119EGLN2BACE1IRAK4CCNC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025147756-A1 | VIRAL SENSITIZERS COMPOSITIONS, METHODS AND USES THEREOF | OTTAWA HOSPITAL RESEARCH INSTITUTE (CA) | 2025-07-17 | — | — | WO | disclosed |